↓ Skip to main content

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Overview of attention for article published in Lancet Oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
37 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
26 Mendeley